Literature DB >> 15995522

Impact of socioeconomic status on the diagnosis to treatment interval in Waldeyer's ring carcinoma.

Karsten Munck1, Mir Jafer Ali, Andrew H Murr, Andrew N Goldberg.   

Abstract

OBJECTIVE: To examine the impact of socioeconomic status on the diagnosis to treatment interval in Waldeyer's ring cancers by comparing the experience of a public hospital and an academic tertiary care medical center.
DESIGN: Retrospective review.
SETTING: Otolaryngology clinic of a public hospital and an academic medical center. PATIENTS: One hundred seven patients with Waldeyer's ring carcinoma who were diagnosed and treated at San Francisco General Hospital (SFGH) or at the University of California, San Francisco Medical Center (UCSFMC) from January 1995 through December 2000 were included in the study. The same departments of otolaryngology-head and neck surgery and radiation oncology staff both hospitals. All radiation therapy was provided at UCSFMC. Patients included in the study had a histologic diagnosis of Waldeyer's ring carcinoma, primary treatment with radiation, and no prior treatment of Waldeyer's ring carcinoma. MAIN OUTCOME MEASURES: The time of diagnosis to start of radiation therapy, dose of radiation, number of treatment days, duration of treatment, and 1 and 3 year survival were recorded. Differences between the two groups were analyzed using Student's t test.
RESULTS: The time course from diagnosis of nasopharyngeal carcinoma to start of radiation therapy was 56 days at SFGH compared with 34 days at UCSFMC. This difference was statistically significant (P = .0001). Difference in diagnosis to treatment intervals for base of tongue cancer was also significant at 66 days at SFGH compared with 31 days at UCSFMC (P = .0038). For cancer of the tonsil, the diagnosis to treatment interval was 70 days at SFGH versus 40 days at UCSFMC (P = .0005). Dose of radiation, number of days of treatment, and duration of treatment were not statistically different. Only patients with cancer of the tonsil demonstrated a statistically significant difference in 3 year survival (P = .0175).
CONCLUSION: Although radiation therapy delivery appears similar between the public and tertiary care medical centers, there appears to be a statistically significant delay in the initiation of therapy for patients at the public institution. It is possible that this influences 3 year survival in cancer of the tonsil.

Entities:  

Mesh:

Year:  2005        PMID: 15995522     DOI: 10.1097/01.MLG.0000165382.83891.92

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  Treatment delay in oral and oropharyngeal cancer in our population: the role of socio-economic factors and health-seeking behaviour.

Authors:  A K Agarwal; Ashwani Sethi; Deepika Sareen; Shruti Dhingra
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-02-08

2.  Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery.

Authors:  Matthew L Rohlfing; Ashley C Mays; Scott Isom; Joshua D Waltonen
Journal:  Laryngoscope       Date:  2017-06-22       Impact factor: 3.325

Review 3.  [Surgical treatment options in oropharyngeal cancer].

Authors:  Herwig Swoboda
Journal:  Wien Med Wochenschr       Date:  2008

4.  Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma.

Authors:  Sonam Sharma; Justin Bekelman; Alexander Lin; J Nicholas Lukens; Benjamin R Roman; Nandita Mitra; Samuel Swisher-McClure
Journal:  Oral Oncol       Date:  2016-03-16       Impact factor: 5.337

5.  Population analysis of socioeconomic status and otolaryngologist distribution on head and neck cancer outcomes.

Authors:  Nitin A Pagedar; Andrew B Davis; Steven M Sperry; Mary E Charlton; Charles F Lynch
Journal:  Head Neck       Date:  2018-12-14       Impact factor: 3.147

6.  Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma.

Authors:  Tyler A Janz; Joanne Kim; Elizabeth G Hill; Katherine Sterba; Graham Warren; Anand K Sharma; Terry A Day; Chanita Hughes-Halbert; Evan M Graboyes
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

7.  What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France.

Authors:  Anne-Valerie Guizard; Olivier Dejardin; Ludivine Launay; Simona Bara; Bénédicte Lapôtre-Ledoux; Emmanuel Babin; Guy Launoy; Karine Ligier
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-27       Impact factor: 2.503

8.  The combined effect of individual and neighborhood socioeconomic status on nasopharyngeal cancer survival.

Authors:  Ting-Shou Chang; Chun-Ming Chang; Ta-Wen Hsu; Yaoh-Shiang Lin; Ning-Sheng Lai; Yu-Chieh Su; Kuang-Yung Huang; Hung-Lung Lin; Ching-Chih Lee
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

9.  Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital.

Authors:  Karina Yu; Marisa Westbrook; Shauna Brodie; Sarah Lisker; Eric Vittinghoff; Vivian Hua; Marika Russell; Urmimala Sarkar
Journal:  OTO Open       Date:  2020-02-06

10.  Customized registry tool for tracking adherence to clinical guidelines for head and neck cancers: protocol for a pilot study.

Authors:  Matthew D Hickey; Sarah Lisker; Shauna Brodie; Eric Vittinghoff; Marika D Russell; Urmimala Sarkar
Journal:  Pilot Feasibility Stud       Date:  2020-02-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.